Serial Number | 97348833 |
Word Mark | ABRYTOP |
Filing Date | Wednesday, April 6, 2022 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Monday, August 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 1, 2022 |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations but not including vaccines or pharmaceuticals for the treatment of respiratory viruses, diseases, and disorders |
Pseudo Mark | ABRY TOP |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 11, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Party Name | TEVA PHARMACEUTICALS USA, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Event Date | Event Description |
Saturday, April 9, 2022 | NEW APPLICATION ENTERED |
Monday, April 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
Monday, September 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, October 12, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 1, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, November 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, November 21, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Thursday, December 15, 2022 | POST PUBLICATION AMENDMENT RECEIVED |
Thursday, December 15, 2022 | TEAS PETITION TO AMEND BASIS RECEIVED |
Tuesday, January 10, 2023 | ASSIGNED TO PETITION STAFF |
Wednesday, January 11, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Friday, January 13, 2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
Tuesday, February 28, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 27, 2024 | SOU EXTENSION 2 FILED |
Wednesday, August 16, 2023 | SOU TEAS EXTENSION RECEIVED |
Wednesday, August 16, 2023 | SOU EXTENSION 1 FILED |
Wednesday, August 16, 2023 | SOU EXTENSION 1 GRANTED |
Friday, August 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, February 27, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, February 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, February 27, 2024 | SOU EXTENSION 2 GRANTED |
Monday, August 19, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, August 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, August 19, 2024 | SOU EXTENSION 3 FILED |
Monday, August 19, 2024 | SOU EXTENSION 3 GRANTED |